Michael Thomas Schweizer

25PUBLICATIONS
137CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsBiomedical imagingMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 17, 2026
Piggybacking Towards Progress for CAR-T Cell Therapy in Prostate Cancer.

|Dec 12, 2025
Molecular subtypes of metastatic prostate cancer: from pathophysiology to diagnosis.

Jeanne M Dsouza, Erolcan Sayar, Michael T Schweizer

|Aug 06, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies.

Hyun Jung Lee, Roman Gulati, Erolcan Sayar

|Aug 23, 2024
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.

Laura S Graham, Nicholas C Henderson, Olesia Kellezi

|Jul 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.

Amanda Broderick, Elizabeth Pan, Jinju Li

Pageof 5